231 filings
Page 12 of 12
6-K
8coubsygka
10 Aug 17
Therapix Biosciences Reports Second Quarter 2017 Financial Results and Provides Business Update
12:00am
6-K
8tuleel0k7wl 05tb
30 Jun 17
Report of Foreign Private Issuer
12:00am
6-K
en2u2r 1km93g
29 Jun 17
Report of Foreign Private Issuer
12:00am
6-K
02j9ks
8 Jun 17
Report of Foreign Private Issuer
12:00am
6-K
b3dl9a
24 May 17
Therapix Biosciences Announces CEO Change
12:00am
6-K
97rfw4jck03qtds5u
8 May 17
Report of Foreign Private Issuer
12:00am
6-K
s9pmb6yt71ldnte5ys1
3 May 17
Therapix Biosciences Announces the Appointment of Josh Blacher as Chief Financial Officer
12:00am
6-K
ho8h6t
5 Apr 17
Therapix Signs Exclusive License Agreement with Yissum for Nasal Drug Delivery Technology
12:00am
6-K
vvb0ddkdf7rr
5 Apr 17
Report of Foreign Private Issuer
12:00am
6-K
044x1cb2
3 Apr 17
Therapix Biosciences Ltd. Announces Full Exercise of Underwriters’ Over-Allotment Option
12:00am
6-K
ie203cezvqfoshm
28 Mar 17
Therapix Biosciences Ltd. Announces Closing of U.S. Initial Public Offering of American Depositary Shares
12:00am